Ju
Julphar
Ras Al Khaimah AEFounded 19802,500 employees
Private CappharmaPrivateOncologyMetabolic
Platform: Gulf Pharma
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemalucimab | JUL-1840 | Phase 2/3 | 1 | CGRP | CeliacMCL | ||
| Gelifutibatinib | JUL-8922 | Approved | 3 | PARP | WMMS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)